BACKGROUND/OBJECTIVES: Whole grains are rich source of nutrients and have shown beneficial effects on human health. This study was designed to systematically review the existing results and quantitatively assess the dose-response relationship of whole grain intake with all-cause and cause-specific mortality. SUBJECTS/METHODS: We searched 'whole grain' or 'whole grains' in combination with 'mortality'' or 'cardiovascular disease' or 'cancer' through the Web of Science and PubMed databases till 20 January 2016. To be eligible for inclusion, publications should be prospective cohort studies and reported the influence of whole grain intake on human mortality. Relative risks (RRs) and 95% confidence intervals (CIs) from the included studies were pooled by a random effects model or fixed effect model. RESULTS: We included 19 cohort studies from 17 articles, with 1 041 692 participants and 96 710 deaths in total, in the analyses. We observed an inverse relationship of whole grain intake with risk of total, cardiovascular disease and cancer mortality. The pooled RR was 0.84 (95% CI 0.81-0.88, n = 9) for total mortality, 0.83 (95% CI 0.79-0.86, n = 8) for CVD mortality and 0.94 (95% CI 0.87-1.01, n = 14) for cancer mortality, comparing the highest intake of whole grain with the lowest category. For dose-response analysis, we found a nonlinear relationship of whole grain intake with risk of total, cardiovascular and cancer mortality. Each 28 g/d intake of whole grains was associated with a 9% (pooled RR: 0.91 (0.90-0.93)) lower risk for total mortality, 14% (pooled RR: 0.86 (0.83-0.89)) lower risk for CVD mortality and 3% (pooled RR: 0.97 (0.95-0.99)) lower risk for cancer mortality. CONCLUSIONS: Our study shows that whole grain intake was inversely associated with risk of total, CVD and cancer mortality. Our results support current dietary guidelines to increase the intake of whole grains. Government officials, scientists and medical staff should take actions to promote whole grains intake.
INTRODUCTION
Whole grains were divided into germ, endosperm and bran. 1 The bran and germ contain many phytochemicals, and the endosperm provides a large amount of starch. Whole grains are rich in dietary fiber, minerals and antioxidants which could help promote human health, including keeping a healthy weight, improving the metabolism, alleviating inflammation, and reducing the risk of various causes. [2] [3] [4] [5] Although whole grain foods were well known for its abundant nutritional value, 92% of US adults had a low daily consumption of whole grain (o 3 servings) with an average of 1 serving per day between 1994 and 1996. 6 From a recent study in the United States, over 60% of adults met daily recommendations of total grain intake, while o8.0% of them paid attention to the whole grain recommended value during 2011 to 2012. 7 A study of American women showed that about 23% of their energy intake came from grains, but only about 5% was come from whole grains. 8 Several recent meta-analyses from prospective cohort studies suggested that whole grains and cereal fiber from whole grain had a beneficial effects on the cardiovascular disease, 9 type 2 diabetes, 10 and cancers. 11 However, the magnitude and type of dose-response relation of whole grain intake with total, CVD and cancer mortality remains unclear.
In this study, we systematically reviewed the available evidence and quantitatively assessed the dose-response relationship of whole grain intake with risk of total and cause-specific mortality.
MATERIALS AND METHODS

Data sources and searches
We did a comprehensive literature search through the databases PubMed and Web of Science for studies reported whole grain intake and mortality till 20 January 2016. The search terms included 'whole grain' or 'whole grains' in combination with 'mortality' or 'cardiovascular disease' or 'cancer'. intake, number of deaths and person-years in each category, were available. Figure 1 shows the process of the literature retrieval and selection. 171 publications from the PubMed database and 172 publications from the Web of Science database met the initial search. After an initial screening based on titles and removing duplicates, we got 56 articles retained. Of these articles, we excluded 28 publications that did not provide relevant data, 6 were excluded because they were meeting abstracts or comments, and 4 publications were excluded because they were reviews.
Quality assessment For quality assessment each study included, we considered items in the guidelines of Strengthening the Reporting of Observational Studies in Epidemiology. 12 We particularly focused on the following main characteristics of the study: the study design, participants' characteristics, assessment of dietary intake, assessment of outcome (that is, mortality), follow-up duration and potential confounding factors in the statistical analysis. Because there was no consensus on the tools to evaluate the quality of observational cohort studies, this article did not give a comprehensive score. Moreover, previous studies have discouraged simple application of such scores. [13] [14] [15] Data extraction We extracted the following data from included studies: publication year, first author, study location and name, follow-up time, number of deaths and participants, person time, participants' age and sex, definition of whole grain or whole grain products, methods for whole grain assessment, confounders adjusted for in the analysis, whole grain intake in each category, type of intake (whole grain products or whole grain), RR and 95% CIs in each category. The extracted RR and 95% CIs per whole grain category were fully adjusted for confounders. If studies 16, 17 provided separate estimate for men and women, we considered it as two independent studies.
Statistical methods
In this meta-analysis, RRs and relevant 95% CIs in each study were pooled using a random effects model or fixed effect model when appropriate. Hazard ratios were reported in 11 publications 5, 8, 16, [18] [19] [20] [21] [22] [23] [24] [25] and were considered approximate measures of RRs.
We evaluated the heterogeneity of included studies by the Cochran Q test and I 2 . 26 Because the power of the Q test is low, the statistically significant level was set to 0.10. 26 We divided the heterogeneity into low (I 2 = 25%), moderate (I 2 = 50%) and high (I 2 = 75%) according to I 2 , which described the percentage of variation caused by heterogeneity rather than sampling error between studies. 27, 28 When there was evidence for a significant heterogeneity (P o 0.10), we combined analysis with a random effects model described by Der Simonian and Laird; 29 otherwise, we used the fixed effect model analysis. For significant heterogeneity among included studies, we continued with a series of subgroup analyses to explore the impact on final summary estimates from the following possible factors: publication year, study duration, area, sex, mean age, number of deaths and disease (only for cause-specific mortality). We assesses publication bias with Egger's test 30 and Begg's test. 31 Sensitivity analyses were used to estimate the influence of each study on the final results.
Six publications reported whole grain, 16, 18, 20, 22, 25, 32 and 11 publications reported whole grain food. 5, 8, 17, 19, 21, 23, 24, [33] [34] [35] [36] For studies reported the intake of whole grain products, we did a conversion according to recent recommendations by Ross et al.
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For studies reporting whole grain intake, the intake was converted into the amount of whole grain by using 28 g as a serving size, unless the paper specified the serving size. For studies reporting the consumption of whole grain products, we thought each serving size of whole grain products included 16 g whole grain.
Finally, for studies in which whole grain products were reported in Figure 1 . Flow chart of study selection. Flow chart shows literature search for prospective cohort studies of whole grain intake in relation to mortality. The influence of whole grain intake B Zhang et al grams, the weights were multiplied by 0.57 (28 g of a whole grain product is~16 g of whole grain) to estimate the whole grain intake. For studies that reported the ranges of intake in each category, the intake in each category was equal to midpoint of interval. For open interval, we referenced the length of adjacent interval 38 (Tables 1 and 2 ). We used the method from Greenland and Longnecker 39 to estimate the dose-response relationship of whole grain intake with risk of total and cause-specific mortality. This method requires the RRs (included 95% CI) and the distribution of deaths, person-years and participants from each category. The distribution of deaths or person-years could be estimated by the total number of deaths or person-years when these were not available. 40 There was a 28 g/d increment of whole grain in dose-response results.
All statistical tests were two-tailed. We did the statistical analyses by Stata 12.0 software (StataCorp LP, College Station, TX, USA).
RESULTS
Nineteen prospective cohort studies from 17 publications were included in our study (Table 1 ). Of them, 9 studies (8 publications) 5, 8, 16, [19] [20] [21] [22] 24 with 661 752 participants and 84 464 deaths reported data on whole grain intake and total mortality. Eight prospective cohort studies (7 publications) 5, 8, 16, 19, 20, 24, 25 including 595 485 participants and 23 482 CVD deaths reported data for whole grain intake and CVD mortality. Fourteen prospective cohort studies (12 publications) 5, 8, [16] [17] [18] 20, 23, [32] [33] [34] [35] [36] with 834 935 participants and 41 715 deaths reported data for whole grain intake and cancer mortality (Tables 1 and 2 ).
The 19 studies were published between 1999 and 2016 with the follow-up time between 4 and 26 years. Participants included in our study were from the America (11 studies), Europe (7 studies) and the Mediterranean area (one study). Among these studies, 7 studies only included men, 7 only included women, and 5 included both men and women. All studies measured the dietary intake by the food frequency questionnaire (FFQ). Of all 17 publications, 6 publications reported on whole grain 16, 18, 20, 22, 25, 32 and 11 publications reported on whole grain food 5, 8, 17, 19, 21, 23, 24, [33] [34] [35] [36] (Table 1 ). In multivariable regression models, the following confounders were the most widely adjusted: age (n = 15), race (n = 7), body mass index (n = 15), physical activity (n = 13), smoking status (n = 17), education level (n = 10), alcohol intake (n = 13), total energy intake (n = 15) and hormone use (n = 10).
Whole grain intake and total mortality We included nine prospective cohort studies, and all of them found whole grain intake had a negative association with the risk of total mortality. We used the random effects model because of significant heterogeneity among the 9 studies (I 2 = 47.3%, P = 0.055). The pooled RR comparing the highest category of intake with the lowest was 0.84 (0.81-0.88), suggesting that higher whole grain intake significantly reduced the risk of total mortality (Figure 2) . No publication bias existed according to Begg's test (P = 0.835) and Egger's test (P = 0.695). The distribution of funnel plots was symmetrical (Supplementary Figure 1A) . The pooled RR was between 0.83 (95% CI: 0.81-0.85) and 0.86 (95% CI: 0.83-0.89) according to the sensitivity analysis ( Supplementary Figure 2A) .
We explored the origin of heterogeneity by the subgroup analyses. Subgroups were divided by publication year (42011 or ⩽ 2011 year), study duration (⩽15, 15-20, 420 years), area (United States, Europe, Mediterranean), sex (women and men, women, men), mean age (⩽ 50 or 450) and number of deaths (o 10 000 or 410 000 deaths). All subgroups showed significant inverse association. We didn't found a significant heterogeneity in subgroups stratified by publication year, study location, mean age, whole grain type and number of deaths (P group heterogeneity 40.05). , cancer mortality RR. The data in the row of HRs are adjusted hazard ratios and 95% CI from original publication.
The influence of whole grain intake B Zhang et al ) ) is absolute whole grain intake. We converted the intake of whole grain products into the intake of whole grain (g/d) here, the details could be found in our text.
The influence of whole grain intake B Zhang et al
Sex and study duration may be the sources of heterogeneity. The negative association of whole grain intake with risk of total mortality was more obvious in the subgroups with participants who were women and with a follow-up time between 15 and 20 years (Supplementary Table 1 ). All of the 9 cohort studies 5, 8, 16, [19] [20] [21] [22] 24 met the condition of dose-response relationship analysis. Each 28 g/d (1 serving per day) intake of whole grain could reduce 9% (pooled RR, 0.91 (0.90-0.93)) risk of all-cause mortality. We also observed a significant nonlinear relationship for whole grain intake with risk of all-cause mortality (P-nonlinearity o 0.0001). We found a steep decline observed before 14 g/d for whole grain intake, followed by a gentler and steady decline at higher intakes. Compared with rare consumption of whole grains, the estimated RRs (95% CIs) of total mortality for intakes of 28 Whole grain intake and cardiovascular mortality We included 8 prospective cohort studies, all of them 5, 8, 16, 19, 20, 24, 25 met the criteria of dose-response relationship analysis, and all reported an beneficial effect of whole grain intake for risk of CVD mortality (RRo 1.00). No obvious significant heterogeneity existed among the studies (I 2 o0.1%, P = 0.948), so we used a fixed effect model. We found that whole grain intake could reduce 17% (pooled RR, 0.83 (0.79-0.86)) risk for CVD mortality comparing highest category with the lowest (Supplementary  Figure 3) .
There was no evidence for publication bias based on Begg's test (P = 0.083) or Egger's test (P = 0.217). The distribution of funnel plots was symmetrical (Supplementary Figure 1b) . In the sensitivity analysis, the pooled RR was between 0.82 (95% CI: 0.79-0.86) and 0.83 (95% CI: 0.80-0.87) (Supplementary Figure 2B) .
For dose-response analysis, the combined RR was 0.86 (0.83-0.89) for a 28 g/d increase of whole grain intake. We found a nonlinear association (P-nonlinearity o0.0001) between whole grains and risk of CVD mortality, with a steep reduction before 14 g/d for whole grain intake, followed by a gentler and steady decline at higher intakes (Supplementary Figure 4) .
Whole grain intake and cancer mortality Among the 14 prospective cohort studies, 9, 10, [18] [19] [20] 22, 25, [34] [35] [36] [37] [38] all met the condition of dose-response relationship analysis. Nine studies reported that whole grain intake had a beneficial effect on the risk of cancer mortality (RR o1.00), but only 1 was statistically significant. The reported RRs from 14 studies were between 0.66 and 1.13.
There was significant heterogeneity among the studies (I 2 = 69.4%, P o 0.001). The pooled RR was 0.94 (0.87-1.01) comparing the highest category with the lowest, suggesting that higher whole grain intake may marginally help lower the risk of cancer mortality (Supplementary Figure 5) . We did not find any evidence for publication bias by Begg's test (P = 0.171) or Egger's test (P = 0.598). The distribution of funnel plots was symmetrical (Supplementary Figure 1C) . In the sensitivity analysis, the pooled RR was between 0.90 (0.87-0.93) and 0.98 (0.94-1.03). No study had a significant impact on the total combined results (Supplementary Figure 2C) .
We continued a series of subgroup analyses to seek the factors of heterogeneity across studies. The study location, mean age, whole grain type and study duration may not be the source of heterogeneity (P group heterogeneity 40.05). But the beneficial effect of whole grain intake on cancer mortality risk was more profound in the studies published after year 2010, those that included both of women and men, those with a follow-up time between 10 and 15 years, those reporting fewer than 1000 deaths, and those reporting on colorectal cancer (Supplementary Table 2 ).
For dose-response meta-analysis, a 28 g/d increase of whole grain intake was with a 3% (pooled RR, 0.97 (0.95-0.99)) lower risk of cancer mortality. We found a nonlinear relationship of (P-nonlinearity = 0.042) whole grains with the risk of cancer mortality. We found a steepest decline curve before 10 g/d for whole grain intake, followed by a flattest decline at intermediate intakes and a relative steep decline at high intakes (Supplementary Figure 6) .
DISCUSSION
This meta-analysis shows that whole grain intake may have a beneficial effect on the risk of all-cause, cardiovascular and cancer mortality. The dose-response analysis demonstrated a significant Figure 2 . Association of whole grain intake with risk of total mortality. Forest plot presents association between whole grain intake and risk of total mortality when comparing the highest to the lowest level of whole grain intake. CI, confidence interval; RR, relative risk.
negative nonlinear relationship of whole grains intake with the risk of total, cardiovascular, and cancer mortality. Each 28 g/d (one serving per day) intake of whole grain was respectively associated with 9%, 14% and 3% reductions of risk. Comparing with the higher ranges of whole grain intake, the curves at lower ranges appeared steeper. These findings support current dietary guidelines to recommend over 3 servings intake of whole grain per day to maintain a long-term health.
Our findings reported a higher intake of whole grain could respectively lower 16 and 17% mortality risk from all-cause and cardiovascular comparing the highest category with the lowest, and that were consistent with the existing evidence from some prospective studies. A 2016 meta-analysis 41 of 20 prospective cohort studies reported a daily increase of 3 servings of whole grains could lower 17, 25 and 10% mortality risk respectively from all causes, cardiovascular disease, and cancer. Another metaanalysis with 13 cohort studies 42 reported a 50 g/d of whole grain intake with a 22% lower risk of total mortality. Meta-analyses of 10 to 12 prospective cohort studies reported 16 to 19% risk reduction in cardiovascular mortality comparing the highest WG intake group with the lowest. [43] [44] [45] The relationship between WG intake and cancer outcomes was not sufficiently clear. In our study, the pooled RR comparing extreme groups of whole grain intake was 0.94 (95% CI, 0.87-1.01), with 1 serving per day increment associated with 3% lower risk. A 2016 meta-analysis 46 of 8 prospective cohort studies reported 24% lower risk of pancreatic cancer comparing extreme groups of whole grain intake. However, according to Zong et al., 43 significantly lower cancer mortality was observed only when daily whole grain consumption exceeded 30 g/d. With regard to cancer subtypes, there were four types of cancer in our analysis. The risk factors and causes of cancer mortality are complex which may have affected on our results. We found the highest whole grain intake was associated with 16% lower mortality risk of colorectal cancer comparing with the lowest, and that was consistent with the existing prospective studies. 16, 47 Aune et al. 11 found a 17% lower risk of colorectal cancer from an increment of 3 servings of whole grains intake each day. Our study did not support the findings of a meta-analysis which indicated the whole grain intake reduced the risk of pancreatic cancer. 46 We found that intake of whole grain had no effect on risk of prostate cancer, endometrial cancer or breast cancer. The effect of whole grain intake on cancer may be partly explained by cancer subtypes, lifestyle and dietary factors, which need to be investigated in further studies.
The protective effect of whole grain intake on mortality can be explained biologically. There were various nutrients in whole grains such as phytoestrogens, vitamins, antioxidants and microelement, which have beneficial influence on colorectal cancer, 48 respiratory system diseases, 49 and chronic inflammatory conditions. 50, 51 Moreover, dietary fibers from whole grain could lower the risk of obesity, cancer, diabetes and cardiovascular disease by adjusting the gut microbiota and metabolism. [52] [53] [54] According to the Nurses' Health Study from diabetic women, bran lowered the risk of total and cardiovascular mortality. 55 Many studies have investigated the effect of whole grain food on allcause and cause-specific mortality, but few studies quantitatively examined the relationship. Further investigations should prove these underlying relationship and mechanisms.
Strengths and limitations There were several strengths in our meta-analysis. A highlight of our meta-analysis was its inclusion of a large number of populations (84 464 deaths among 661 752 participants) from almost all of prospective cohort studies reporting whole grain intake and mortality. That greatly reduced the potential selection and recall bias. We also standardized the intake of whole grains to reduce heterogeneity among individual studies. So we had enough statistical power to test the effect of whole grain intake on all-cause mortality. And we also found a negative relationship in most subgroup analyses. For sensitivity analyses, we found that individual studies have little effect on the outcome. Another highlight of this present meta-analysis was that whole grain intake had a negative nonlinear relationship with risk of total, cardiovascular and cancer mortality by quantitative doseresponse analyses.
Our meta-analysis also had limitations. Firstly, there were relatively few studies eligible for inclusion. So the power of publication bias may be limited due to the low number of cohort studies. And the results of linear and nonlinear relationship should be interpreted with caution. In addition, the results in very high ranges were based on relatively few data points and should be interpreted with caution. We could not rule out the possibility of confounding factors, but we found there was still negative association in several subgroup analyses.
Another limitation was that studies included had some differences: reported whole grain food or absolute whole grain intake, the dietary measurement method and the definition of whole grains. Most publications reported whole grain food, while only six publications directly reported absolute whole grain, and most studies used FFQs to collect dietary data. These may be a source of the heterogeneity although we unified the unit and did a transform among whole grain and whole grain food in our study. It was difficult to accurately assess intake in epidemiological investigation because of the limited food items, thus whole grain intake could be underestimated. Several American studies considered food that contained over 25% weight of whole grain or bran as whole grain food, and several studies did not report its definition. Thus, it was hard to assess the influence of different definitions on the results. We strongly recommend that future studies should report the definitions in articles and the dry weight of whole grain consumption.
CONCLUSION
Our meta-analysis suggested that whole grain intake may have a beneficial effect on total and cause-specific mortality. Our results support current dietary guidelines to increase the intake of whole grains. Government officials, scientists and medical staff should take actions to promote whole grains consumption.
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